No Detail Found!

Effectiveness of low-dose intradermally administered hepatitis B virus vaccine.

Author(s)
Tahir Shafi Nephrology Department, Microbiology National Health Research Complex, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan
Jamila Iqbal Nephrology Department, Microbiology National Health Research Complex, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan
Muhammad Shahid Nephrology Department, Microbiology National Health Research Complex, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan
Abstract
Hepatitis B vaccine is underutilized due to high cost. A study was performed to see the effectiveness of yeast derived recombinant vaccine in low dose (0.1 ml; 2/tog) give at 0, 1,2 and 6 months in 50 seronegative individuals. Out of them 39 subjects (78%) developed anti-hepatitis B surface antigen (anti HBs) in a concentration greater than 10 IU/L which is considered to be protective. None of them had any significant side effect except for minor local soreness at the site of injection.
Publication Details
Page(s) 144-146
DOI DOI not available
Published Journal: Pakistan Journal of Medical Research, Volume: 31, Issue: 3, Year: 1992

Request the full text from PASTIC

0

Citations

0

Downloads

40

Views